AI Testing, Inspection and Certification (TIC) Services in Healthcare Market Trends

AI TIC Services in Healthcare Market Trends

The growing integration of AI in drug discovery and development is enabling faster identification of drug candidates, predicting drug efficacy and enhancing clinical trials. Companies are launching AI-based software to integrate drug discovery. For instance, in December 2023, Merck, a science and technology company launched AIDDISON, drug discovery software, a software-as-a-service platform to close the gap between virtual molecule design and real-world manufacturability through Synthia retrosynthesis software API integration. The integration of AI in drug discovery needs accurate testing and certification to ensure AI models are reliable. AI TIC services are important for verifying AI-driven drug discovery processes and checking if they meet regulatory standards.
 

Also, regulatory bodies in various countries are updating their regulations for AI-driven medical devices.  For instance, in May 2024, The FDA (Food and Drug Administration) in the United States has announced updated guidelines for the regulation of AI-driven medical devices. The new guidelines emphasize the importance of rigorous testing and validation of AI algorithms used in healthcare to ensure safety, efficacy, and compliance with regulatory standards. This update reflects ongoing efforts to streamline the approval process for AI technologies while maintaining patient safety.